Adriamycin sensitizes adriamycin-resistant HL-60/ADR cells to TRAIL-mediated apoptosis

Ke Hong; Yiyu Wang; Dongming Ren; Lei Wang

doi:10.1007/s11805-008-0354-2

ScienceGate Book Chapters

JOURNAL ARTICLE

Adriamycin sensitizes adriamycin-resistant HL-60/ADR cells to TRAIL-mediated apoptosis

Ke Hong Yiyu Wang Dongming Ren Lei Wang

Year: 2008 Journal: Chinese Journal of Clinical Oncology Vol: 5 (5)Pages: 354-360 Publisher: Springer Nature

DOI: 10.1007/s11805-008-0354-2

Get Full-Text PDF Get Analytical Report

Keywords:

XIAP Apoptosis Caspase 8 Cytotoxicity MTT assay Survivin Caspase Viability assay Caspase-9 Chemistry Caspase 3 Molecular biology Inhibitor of apoptosis Programmed cell death Cell biology Biology Biochemistry In vitro

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

0.08

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Cell death mechanisms and regulation

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

PARP inhibition in cancer therapy

Health Sciences → Medicine → Oncology

NF-κB Signaling Pathways

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

Adriamycin sensitizes adriamycin-resistant HL-60/ADR cells to TRAIL-mediated apoptosis

Metrics

Citation History

Topics

Related Documents

Silencing of Prion Protein Sensitizes Breast Adriamycin-Resistant Carcinoma Cells to TRAIL-Mediated Cell Death

Response to adriamycin of transplasma membrane electron transport in adriamycin-resistant and nonresistant HL-60 cells

Tyrosine and phenylalanine restriction sensitizes adriamycin‐resistant P388 leukemia cells to adriamycin

Synergistic Effect of Baicalin and Adriamycin in Resistant HL-60/ADM Leukaemia Cells

PARP inhibitor re‑sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis